Literature DB >> 34290572

Factors influencing pre-exposure prophylaxis uptake among current users: A qualitative study.

Gloria Aidoo-Frimpong1, Kennethea Wilson1, Sarahmona Przybyla1.   

Abstract

Daily oral pre-exposure prophylaxis is an effective strategy for HIV prevention; yet, uptake has been lower than anticipated. This study explores the factors that influenced current users' decisions to initiate PrEP in Western New York. Qualitative data from 41 semi-structured interviews were thematically analyzed. Participants' decision to initiate PrEP was based on individual, interpersonal and structural factors. PrEP users initiated when there was an increase in knowledge, risk perception, sexual health communication, and PrEP access. Findings suggest for PrEP to maximize its HIV prevention potential, public health interventions that utilize a multi-level approach may be most impactful to increase uptake.

Entities:  

Keywords:  HIV prevention; pre-exposure prophylaxis; qualitative study

Year:  2020        PMID: 34290572      PMCID: PMC8291342          DOI: 10.1080/15381501.2020.1810838

Source DB:  PubMed          Journal:  J HIV AIDS Soc Serv        ISSN: 1538-1501


  13 in total

1.  Implications for PrEP Uptake in Young Adults Experiencing Homelessness: A Mixed Methods Study.

Authors:  Diane Santa Maria; Kathryn R Gallardo; Sarah Narendorf; Robin Petering; Anamika Barman-Adhikari; Charlene Flash; Hsun-Ta Hsu; Jama Shelton; Kristin Ferguson; Kimberly Bender
Journal:  AIDS Educ Prev       Date:  2019-02

2.  Integrating HIV Preexposure Prophylaxis (PrEP) Into Routine Preventive Health Care to Avoid Exacerbating Disparities.

Authors:  Sarah K Calabrese; Douglas S Krakower; Kenneth H Mayer
Journal:  Am J Public Health       Date:  2017-10-19       Impact factor: 9.308

3.  Facilitators and Barriers to Pre-Exposure Prophylaxis (PrEP) Use Among Black Individuals in the United States: Results from the National Survey on HIV in the Black Community (NSHBC).

Authors:  Bisola O Ojikutu; Laura M Bogart; Molly Higgins-Biddle; Sannisha K Dale; Wanda Allen; Tiffany Dominique; Kenneth H Mayer
Journal:  AIDS Behav       Date:  2018-11

4.  The prevalence of pre-exposure prophylaxis use and the pre-exposure prophylaxis-to-need ratio in the fourth quarter of 2017, United States.

Authors:  Aaron J Siegler; Farah Mouhanna; Robertino Mera Giler; Kevin Weiss; Elizabeth Pembleton; Jodie Guest; Jeb Jones; Amanda Castel; Howa Yeung; Michael Kramer; Scott McCallister; Patrick S Sullivan
Journal:  Ann Epidemiol       Date:  2018-06-15       Impact factor: 3.797

Review 5.  Next-Wave HIV Pre-Exposure Prophylaxis Implementation for Gay and Bisexual Men.

Authors:  Sarit A Golub; Julie E Myers
Journal:  AIDS Patient Care STDS       Date:  2019-05-16       Impact factor: 5.078

6.  Predictors of PrEP Uptake Among Patients with Equivalent Access.

Authors:  Sarit A Golub; Rachel A Fikslin; Matthew H Goldberg; Stephanie M Peña; Asa Radix
Journal:  AIDS Behav       Date:  2019-07

7.  Barriers and Facilitators to Oral PrEP Use Among Transgender Women in New York City.

Authors:  Christine Tagliaferri Rael; Michelle Martinez; Rebecca Giguere; Walter Bockting; Caitlin MacCrate; Will Mellman; Pablo Valente; George J Greene; Susan Sherman; Katherine H A Footer; Richard T D'Aquila; Alex Carballo-Diéguez
Journal:  AIDS Behav       Date:  2018-11

8.  Provider-Patient Communication on Pre-Exposure Prophylaxis (Prep) for HIV Prevention: An Exploration of Healthcare Provider Challenges.

Authors:  Kennethea Wilson; Jacob Bleasdale; Sarahmona M Przybyla
Journal:  Health Commun       Date:  2020-07-07

Review 9.  Improving PrEP Implementation Through Multilevel Interventions: A Synthesis of the Literature.

Authors:  Rogério M Pinto; Kathryn R Berringer; Rita Melendez; Okeoma Mmeje
Journal:  AIDS Behav       Date:  2018-11
View more
  1 in total

1.  Exploring the Role of Provider-Patient Communication in Women's Sexual Health and Pre-Exposure Prophylaxis Care in the Primary Care Settings in New York State of the United States.

Authors:  Chen Zhang; Kevin Fiscella; Yu Liu
Journal:  Int J Environ Res Public Health       Date:  2022-07-01       Impact factor: 4.614

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.